Back to video list Back to Home Prof Goadsby, can you comment on the dosing schedule of eptinezumab? Does it differ from episodic to chronic migraine patients? Migraine with or without aura? You may also like Alzheimer's Disease Parkinson's Disease Article Dementia and COVID-19: a conjunction of pandemics Depression Article Offering further support Parkinson's Disease Congress highlights Article Hot topics in Parkinson’s disease research from AAN Virtual 2022 Schizophrenia Article Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden